Literature DB >> 11757056

Study of smoking behavior in asbestos workers.

Omowunmi Y O Osinubi1, Aboaba A Afilaka, John Doucette, Anne Golden, Theresa Soriano, Elisheva Rovner, Edward Anselm.   

Abstract

BACKGROUND: Asbestos exposure and concomitant cigarette smoking markedly increase the risk of lung cancer and contribute to the prevalence and severity of pulmonary interstitial fibrosis.
METHODS: A cross-sectional survey of 214 asbestos workers was initiated to determine the prevalence of smoking and their readiness to quit smoking using the stage of change theory.
RESULTS: The study was comprised of 61 never smokers (28.5%), 118 ex-smokers (55.1%), and 35 current smokers (16.4%). Reasons for smoking cessation in ex-smokers included perception of ill-health (51%) and knowledge of smoking-asbestos hazards (3.4%). Stage of change of current smokers revealed: precontemplation (26.5%), contemplation (35%), preparation (29%), and action (8.8%). Current smokers had the highest prevalence of small airway obstruction on spirometry.
CONCLUSIONS: A detailed smoking history during medical surveillance activities will enable the occupational physician to identify asbestos workers who have difficulty quitting and to develop a system in which such individuals can be referred to comprehensive smoking cessation programs. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11757056     DOI: 10.1002/ajim.10031

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  2 in total

1.  If smoking increases absences, does quitting reduce them?

Authors:  J L Sindelar; N Duchovny; T A Falba; S H Busch
Journal:  Tob Control       Date:  2005-04       Impact factor: 7.552

2.  Mesothelioma in a developing country: a retrospective analysis of the diagnostic process.

Authors:  Paulo Henrique Peitl Gregório; Ricardo Mingarini Terra; Leonardo Pontual Lima; Paulo Manuel Pêgo-Fernandes
Journal:  J Bras Pneumol       Date:  2022-08-19       Impact factor: 2.800

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.